1
High infection attack rates of SARS-CoV-2 in Dutch households revealed by
dense sampling
Daphne F.M. Reukers
1
Michiel van Boven
1
Adam Meijer
1
Nynke Rots
1
Chantal Reusken
1
Inge Roof
1
Arianne B. van Gageldonk-Lafeber
1
Wim van der Hoek
1*
Susan van den Hof
1*
1
Centre for Infectious Disease Control, National Institute for Public Health and the Environment,
Bilthoven, the Netherlands
*
These authors contributed equally
Corresponding author
Daphne F.M. Reukers
Centre for Epidemiology and Surveillance of Infectious Diseases, Centre for Infectious Disease
Control (CIb), National Institute for Public Health and the Environment (RIVM)
PO Box 1, 3720 BA Bilthoven, the Netherlands
Tel.: +31 302743419
E-mail: Daphne.Reukers@rivm.nl
WORD COUNT ABSTRACT: 236; WORD COUNT MAIN TEXT: 2,913
Key points: We analyze data from a SARS-CoV-2 household study and find higher secondary attack
rates than reported earlier. We argue that this is due to a dense sampling strategy that includes
sampling at multiple time points and of multiple anatomical sites.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in(which was not certified by peer review)preprint
The copyright holder for thisthis version posted January 26, 2021. ; https://doi.org/10.1101/2021.01.26.21250512doi: medRxiv preprint
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
2
Abstract
Background
Indoor environments are considered a main setting for transmission of SARS-CoV-2. Households in
particular present a close-contact environment with high probability of transmission between
persons of different ages and with different roles in society.
Methods
Complete households with a laboratory-confirmed SARS-CoV-2 positive case in the Netherlands
(March-May 2020) were included. At least three home visits were performed during 4-6 week of
follow-up, collecting naso- and oropharyngeal swabs, oral fluid, faeces and blood samples for
molecular and serological analyses of all household members. Symptoms were recorded from two
weeks before the first visit up to the last visit. Secondary attack rates (SAR) were estimated with
logistic regression. A transmission model was used to assess transmission routes in the household.
Results
A total of 55 households with 187 household contacts were included. In 17 households no
transmission took place, and in 11 households all persons were infected. Estimated SARs were high,
ranging from 35% (95%CI: 24%-46%) in children to 51% (95%CI: 39%-63%) in adults. Estimated
transmission rates in the household were high, with reduced susceptibility of children compared to
adolescents and adults (0.67; 95%CI: 0.40-1.1).
Conclusion
Estimated SARs were higher than reported in earlier household studies, presumably owing to a
dense sampling protocol. Children were shown to be less susceptible than adults, but the estimated
SAR in children was still high. Our results reinforce the role of households as main multiplier of SARS-
CoV-2 infection in the population.
Key words: SARS-CoV-2, COVID-19, Secondary Attack Rate, Household study, Transmission model
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in(which was not certified by peer review)preprint
The copyright holder for thisthis version posted January 26, 2021. ; https://doi.org/10.1101/2021.01.26.21250512doi: medRxiv preprint
3
Introduction
The first case of the coronavirus disease (COVID-19) emerged in Wuhan in December 2019 [1].
Starting with an outbreak of pneumonia of unknown etiology, the causative agent severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified early January 2020 [2]. Since then,
the virus has spread rapidly across the world [3].
Evidence from case and cluster reports shows that SARS-CoV-2 is largely spread through respiratory
droplets from infected persons, with proper distance and indoor air ventilation being significant
factors reducing the risk of transmission [4]. Therefore, social distancing measures are important to
reduce transmission, and most countries have instated strategies based on this premise. In the
Netherlands, the first COVID-19 case was detected on February 27 [5]. In March, the Dutch
government mandated a partial lockdown, characterized by social distancing, self-quarantine and
self-isolation orders, closing of schools, bars, and restaurants, and urging people to work from home
[6]. These measures generally increased the time spent at home. As household members live in close
contact it is difficult to attain a proper physical distance after a COVID-19 diagnosis of a household
contact. In combination with evidence that a sizeable fraction of transmission events occur
pre-symptomatically, the household constitutes a high risk setting for SARS-CoV-2 transmission [7].
The secondary attack rate (SAR) of SARS-CoV-2 infection among household contacts is a useful
measure to gauge the risk of transmission in this close-contact setting. It provides insight in the
susceptibility of contacts and infectiousness of cases given certain characteristics, such as age,
gender, household size, and severity of infection. Household studies performed in the first six
months of the pandemic, mostly in China, found a relatively high household SAR of 15-22% [8]. In
most countries, paediatric patients are underrepresented in the statistics of the COVID-19 outbreak
and children usually exhibit mild symptoms [9, 10]. If children have lower susceptibility or
infectiousness, this can have important implications for strategies to curb the spread of SARS-CoV-2.
Previously household studies observed that the SAR was significantly higher for adult contacts
compared to child contacts [11]. However, most studies only tested household contacts with COVID-
19 related symptoms, relied on RT-PCR in nasopharyngeal swabs only, and did not perform any
follow-up sampling. These studies may have missed mild, pre- or asymptomatic cases, especially in
children [12, 13]. In the present study all household contacts were tested as soon as possible after a
laboratory-confirmed infection in the household was established, and subsequently followed-up for
4 to 6 weeks. A dense sampling strategy was employed that included sampling from various
anatomical sites while using multiple molecular and serological diagnostic methods to establish
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in(which was not certified by peer review)preprint
The copyright holder for thisthis version posted January 26, 2021. ; https://doi.org/10.1101/2021.01.26.21250512doi: medRxiv preprint
4
infection. This increases the chance of detecting every SARS-CoV-2 infected household contact and
of determining transmission routes, including asymptomatic transmission, as accurately as possible
[8]. Main aims of this study were to estimate secondary attack rates and to determine factors that
impact susceptibility and infectiousness, with a specific focus on age of household contacts.
Methods
This study is an update of a generic stand-by protocol drafted in 2006 to quickly initiate scientific
research in the case of an outbreak of an emerging pathogen [14]. The generic protocol was tailored
to the current COVID-19 pandemic with input from the WHO First Few Hundred protocol [15]. The
generic and adapted study protocols were approved by the Medical-Ethical Review Committee of
the University Medical Center Utrecht (NL13529.041.06). A prospective cohort study was performed
following households where one household member was tested positive for SARS-CoV-2 in the
period March 24-April 6 2020 (one household was included later on May 24).
Population
Any person 18 years and older testing positive for SARS-CoV-2 who had at least one child in their
household below the age of 18 and consented to be contacted for scientific research were reported
by the Public Health Service of the region Utrecht. We contacted this person (i.e. the index case) to
request enrolment of the entire household in this study. Every household contact (persons living in
the same house as the index patient) was to be enrolled in the study, except for contacts below the
age of one year. Households were excluded if one or more of the household contacts did not want
to participate in the study upfront, as in that case it would not be possible to fully determine
household transmission patterns.
Data collection
Two research nurses performed the first home visit within 24 hours after inclusion to collect the
informed consent forms and the first samples from all participants (see Table 1 for schedule of
sample collection). Household contacts completed a questionnaire to collect demographic
characteristics, medical history, travel history, anti-viral drug use, symptoms, symptom onset and
hospital admission. Participants reported whether they had symptoms in the 2 weeks prior to the
first visit. After the first visit, they filled in a symptoms diary for 2 weeks. A second visit was included
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in(which was not certified by peer review)preprint
The copyright holder for thisthis version posted January 26, 2021. ; https://doi.org/10.1101/2021.01.26.21250512doi: medRxiv preprint
5
at 2-3 weeks post-inclusion, and at the last home visit at 4-6 weeks post-inclusion, participants
reported whether they had developed symptoms in the weeks between the second and third home
visit. We defined three age strata: adults 18 years of age or older, adolescents 12 to 17 years of age
(corresponding to secondary school age) and children 1 to 11 years of age (corresponding to day
care and primary school age).
Molecular diagnostics and serological analysis
Total nucleic acid was extracted from the nasopharyngeal swab (NP), oropharyngeal swab (OP), oral
fluid and faeces specimens using MagNApure 96 with total nucleic acid kit small volume and elution
in 50 µl. RT-qPCR was performed on 5 µl extract using TaqMan® Fast Virus 1-Step Master Mix
(Thermo Fisher) on Roche LC480II thermal cycler with SARS-like beta coronavirus (Sarbeco) specific
E-gene primers and probe as described previously [16]. As no other Sarbeco viruses are currently
detected in humans, a positive Sarbeco E-gene RT-qPCR is validly taken as positive for SARS-CoV-2.
The results of the NP and OP swabs were combined to one result: upper respiratory tract (URT)
negative (NP and OP negative) or positive (NP and/or OP positive). For detection of antibodies
against SARS-CoV-2 we used the Wantai total Ig ELISA as described previously [17].
Classification of index and primary case
Laboratory-confirmed SARS-CoV-2 infection was defined as, either at least one positive PCR on any
of the clinical samples taken during follow-up and/or detection of antibodies at any sampling
timepoint. Every index case was by definition infected, as they had at least one positive PCR on an
URT swab.
Symptoms and severity of COVID-19
The day of symptom onset as reported by the participant was set as the first day of illness.
Participants were considered symptomatic if at least one of the following symptoms occurred at any
timepoint: respiratory symptoms (including sore throat, cough, dyspnoea or other respiratory
difficulties, rhinorrhoea), fever, chills, headache, anosmia or ageusia, muscle pain, joint ache,
diarrhoea, nausea, vomiting, loss of appetite or fatigue. For household contacts, symptom onset
occurring more than 2 weeks prior to the first day of illness or first positive test result of the index
case were considered not related to SARS-CoV-2 transmission within the household.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in(which was not certified by peer review)preprint
The copyright holder for thisthis version posted January 26, 2021. ; https://doi.org/10.1101/2021.01.26.21250512doi: medRxiv preprint